The authors describe a case of neurologic involvement in mild hyperphenylal
aninemia (HPA), not due to tetrahydrobiopterin (BH4) deficiency, with low l
evels of monoamine neurotransmitter metabolites in CSF. The combined BH4-Ph
e loading test suggested a BH4 response, confirmed by clinical improvement
after BH4 therapy. Molecular study revealed a compound heterozygosity of th
e phenylalanine hydroxylase alleles: a mild HPA-associated mutation (T380M)
and the new mutation D151E. This case demonstrates that even mild HPA, gen
erally considered a benign disorder, may present neurologic impairment.